Drug Shortage Report for GD-GABAPENTIN

Last updated on 2018-02-07 History
Report ID 33910
Drug Identification Number 02285843
Brand name GD-GABAPENTIN
Common or Proper name GD-GABAPENTIN
Company Name GENMED A DIVISION OF PFIZER CANADA ULC
Active Ingredient(s) GABAPENTIN
Strength(s) 600MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 100's
ATC code N03AX
ATC description ANTIEPILEPTICS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2018-01-02
Estimated end date
Actual end date 2018-02-05
Shortage status Resolved
Updated date 2018-02-07
Company comments Please note that only 1 lot with an expiry date of 6/30/2018 remains available.
Health Canada comments
Contact Address 17300 TRANS CANADA HIGHWAY
KIRKLAND, QUEBEC
CANADA H9J 2M5
Company contact information Customer Service / service à la clientèle : 1-800-387-4974 Email / courriel: PharmaCustomerServiceDept@pfizer.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v7 2018-02-07 French Compare
v6 2018-02-07 English Compare
v5 2018-01-19 French Compare
v4 2018-01-19 English Compare
v3 2018-01-05 English Compare
v2 2017-12-20 French Compare
v1 2017-12-20 English Compare